Effects of Autogenic and Reciprocal Inhibition on Trapezitis

October 11, 2023 updated by: Riphah International University

Comparative Effects of Autogenic and Reciprocal Inhibition Techniques on Pain, Disability and Range of Motion Among Smart Phone User With Trapezitis

Aim of my study is to compare two techniques of METS i.e., autogenic and reciprocal inhibition techniques on pain, disability and Range of motion among smart phone user with trapezitis.

Study Overview

Status

Recruiting

Conditions

Detailed Description

Study focuses trapezitis in smart phone users. There are many different causes of neck pain, but one common factor is upper trapezitis. This refers to pain and spasms in the neck caused by inflammation of the trapezius muscle. The aim of this study is to compare the effects of autogenic and reciprocal inhibition techniques on pain, range of motion and disability among smart phone user with trapezitis.

This study will be randomized clinical trial and 40 patients male and female with age 20 to 40 years having NPRS >3 according to inclusion criteria will be included in the study. They will be allocated into 2 groups by non-probability convenience sampling technique. Group A will receive autogenic inhibition technique with conventional physical therapy while Group B will receive reciprocal inhibition technique with conventional therapy. Outcome measures; Neck Disability Index, goniometry and Numeric Pain Rating Scale will measure neck function and neck pain intensity. Total 12 sessions, 3 sessions per week for 4 weeks were provided. Each session was 45 minutes long and measurements will be taken at the baseline and at the end of 4th week. Data will be analyzed by SPSS version 25

Study Type

Interventional

Enrollment (Estimated)

42

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Punjab
      • Lahore, Punjab, Pakistan, 16454
        • Recruiting
        • Nusrat Rashid Medical Complex
        • Contact:
        • Principal Investigator:
          • Muhammad Awais Hassan, MS

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Mobile phone users age between 20 -40 years old.
  • Both gender male and female included.
  • Neck pain (Numeric Pain Rating Scale >3)
  • With limited Neck ROMs.
  • NDI scoring 15-24points (30-48%) moderate disability

Exclusion Criteria:

  • Neck pain with whiplash or headache, neurological disorder.
  • History of previous head, neck, cervical spine or shoulder surgery.
  • Infection or inflammatory arthritis in the cervical spine.
  • Trigger point of Upper trapezius will be excluded.
  • History of cervical radiculopathy.
  • Diagnosed fibromyalgia and myopathy.
  • History of cancer.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: autogenic inhibition
isometric of muscles and stretching of the same side
Group 1 will receive AI-MET with conventional treatment. AI include stretching of the affected muscle and performing isometric contraction with 50% of the total patient's effort in the same muscle that will being stretched and position hold for 10 seconds, with 5 seconds of rest after every repetition. This procedure will repeat 5 times.
Experimental: reciprocal inhibition
isometric of muscles and stretching of the opposite side
Group 2 receive RI-MET with conventional treatment. The RI also include stretching of the affected muscle but contrary to AI, isometric contraction of the antagonist muscles with the 50% of total patient's effort will follow. This position holds for 10 seconds, while agonist's muscle will still in the stretched position, with 5 seconds of rest after every repetition. This procedure will repeat 5 times too.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Goniometry
Time Frame: 4 weeks
The art and science of measuring the joint ranges in each plane of the joint are called goniometry. The term 'goniometry' has its origin from two Greek words, gonia, which means angle, and metron, which means to measure. Goniometer is a device that measures an angle or permits the rotation of an object to a definite position. A universal goniometer has three parts. The fulcrum and the body are placed over the joint being measured. The stationary arm is the arm of the goniometer that aligns with the inactive part of the joint measured. It is structurally a part of the body and is not movable independently of the body. The moving arm is the arm of the goniometer, which aligns with the mobile part of the joint measured. Neck flexion, extension, side bending and rotation will be assessed through it
4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
NPRS (numeric pain rating scale)
Time Frame: 4 weeks
The Numeric Pain Rating Scale (NPRS) (an outcome measure) that is a unidimensional measure of pain intensity in adults. The NPRS is a segmented numeric version of the visual analog scale. The common format is a horizontal bar or line. Although various iterations exist, the most commonly used is the 11-item NPRS. The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable"). The NPRS is a segmented numeric version of the visual analog scale (VAS) in which a respondent selects a whole number (0-10) that best reflects the intensity of his/her pain 11-point numeric scale ranges from '0' representing no pain to 10 representing the worst imaginable pain. Reliability of NPRS is (r=0.96 and 0.95) and validity is from 0.86 to 0.95
4 weeks
NDI (neck disability index)
Time Frame: 4 weeks
The Neck Disability Index (NDI) (modification of the Oswestry Low Back Pain Disability Index). This questionnaire has been designed to give us information as to how your neck pain has affected your ability to manage in everyday life. The NDI has become a standard instrument for measuring self-rated disability due to neck pain. Each of the 10 items scores from 0 to 5. Scoring for each section the total possible score is 5: if the first statement is marked the section score = 0, if the last statement is marked it = 5. The maximum score is 50 (20). Reliability of NDI is 0.50 and 0.98
4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Humera Mubashar, MS, Riphah International University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 10, 2023

Primary Completion (Estimated)

November 30, 2023

Study Completion (Estimated)

December 1, 2023

Study Registration Dates

First Submitted

October 11, 2023

First Submitted That Met QC Criteria

October 11, 2023

First Posted (Actual)

October 17, 2023

Study Record Updates

Last Update Posted (Actual)

October 17, 2023

Last Update Submitted That Met QC Criteria

October 11, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • REC/RCR & AHS/23/0145

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Neck Pain

Clinical Trials on autogenic inhibition

3
Subscribe